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Ultrasound and biochemical Undings in intrauterine growth retardation
J. Kunz, P. J.Keller
Universitäts-Frauenklinik Zürich
The early recognition of fetal maldevelopment due
to chronic placental insufficiency is of decisive
importance if perinatal mortality and morbidity
are to be further reduced. This can be achieved by
direct and indirect methods, i.e. cephalometry and
thoracometry using ultrasound on the one hand,
and biochemical tests of the function of the feto-
placental unit, on the other. Estriol, pregnandiol
and HPL levels and some placental enzymes are
here of special interest. In this investigation an
attempt was made to asses the diagnostic value of
the various parameters and to suggest when they
should be used.
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er and child during preg-
nancy and delivery.
l Material and method
A total of 83 patients presently, or with a case
history of risk hospitalised because of suspect
placental insufficiency, was investigated. Twin
pregnancies and those with doubtful duration were
excluded. In the third trimester of pregnancy the
following determinations were made: An average
of 4 determinations of the biparietal head diameter
using the B-scan method (Vidoson), 10 determi-
nations of estriol and 3 of pregnandiol in urine
[13, 50] and 6 HPL determinations in the semm
[49], 7 determinations of heat stable alkaline phos-
phatase (HSAP) [9], all per individual case. Bi-
parietal head diameter values were transferred to a
Standard curve that was in agreement with the one
reported by HOLLÄNDER [42]. Growth retarda-
tion was assumed if the last two values showed the
same trend with the date being certain and were
below two Standard deviations or showed de-
creased progress. Biochemical parameters were
considered to be pathological if they were below
95% of the normal values, with two values being
outside this normal ränge or with 3 or more values
being continuously below the 95% normal ränge.
Maturity was assessed after birth from neurological
and somatic signs of maturity according to D u BÖ-
WITZ [25]. Infants were diagnosed äs small for
date if their birth weight was below the lOth per-
centile on the LUBCHENKO curve [62].
2 Results
Fifteen of the 83 newborn were small for dates.
Five had a gestational age of less than 37 weeks, 4
in the 35/36 week and one in the 30.5 week. A
further 11 prematures was in the group of 68
normotrophic children.
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Fig. l shows that there is a good correlation be-
tween biparietal head diameter and body weight.
However, only 3 out of the 15 small for date in-
fants were below the lower limit of the norm. The
remaining 81 (98%) were within nonnal limits,
71 % below the curve for mean values. In twelve
SGA infants the head diameter was normal pre-
natally and increased normally.
Fig. 2 shows a very good correlation between weight
percentile and the percentage deviation from the
normal mean of estriol excretion. In all SGA cases
values were found to be decreased. Ten were out-
side the 95% normal limits and 5 were still at least
40% below those limits. In infants with body
weights between the lOth and 50 th percentile
estriol values were below, the normal mean in 44%.
Weight percentiles and HPL concentration in
maternal serum (Fig. 3) also correlated well. In 8
out of 15 SGA infants values were below the 95%
normal r nge. In 7 cases HPL maternal values were
above the mean. For normal infants reliability was
68% but in 19% there was a false positive fmding.
Inspite of a proper correlation pregnandiol determi-
nations showed up only one of the SGA infants
(Fig. 4).
In contrast to the three hormonal parameters there
was no correlation between weight percentile and
the percentage deviation of the HSAP concentration
from the mean (Fig. 5). Five SGA values were be-
low the 95% r nge and 9 below the mean value.
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Fig. 2. Relationship between estriol excretion in 24-hr urine and infant weight
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Fig. 3. Relationship between serum HPL concentration and infant weight
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Fig. 5. Relationship between serum HSAP concentration and infant weight
*80 *100 HSAP
% Devia t ion f rom mean
of serum concentration
J. Perinat. Med. 4(1976)
Kunz et al., Findings in intrauterine growth retardation 89
3 Discussion
Cephalography gave a good correlation between
body weight and biparietal diameter. Three of the
15 SGAs were diagnosed echographically. In 12
the diameter was normal and increased normally
prenatally. The linear relationship between bi-
parietal diameter and infant weight has been
described [39, 70,82]. HOLLÄNDER [43] diagnosed
45% of SGAs from the absolute diameter, HINSEL-
MANN [42] could predict growth retardation from
the 30th week of pregnancy onwards in 70% of
cases. The poor prognostic value of the diameter
in our series is not surprising, since chronic placental
insufficiency which is expressed only in the last
trimester affects brain and cranial growth only
slightly and least of all organs [35, 36,43]. This is
in contrast to the effects of early impairment of
fetal growth. Fetal retardation is better diagnosed
from low weekly growth rates considered to be
0.16 cm [90]to0.18 cm [86]. CAMPBELL [15] uses
this to diagnose 68% of SGAs with 18% false
positives. Similar data have been reported by
others [15, 36,41,43, 55,59,90]. Fetal abdominal
circumference or additional thoracometry [37]
were reliable up to 75% and thus better than the
head diameter. However reference points are
required to make these reproducible. A diameter
of 8.5 to 9.4 cm at term indicates a weight of
more than 2500 g [11, 43, 54, 57, 58, 82, 86]. In
addition several formulas for calculating birth
weight from echographically determined values
have been suggested [4,39,45, 53, 54, 58, 81, 86,
92]. Inspite of a reliability of 68 to 90% deviations
in body weight between 300 to 500 g were found.
All agree that cephalometry can diagnose growth
retardation only if at least three determinations
are made at weekly intervals for 2 weeks.
In contrast to a few others [34, 46, 51, 87] we
found a good correlation between body weight
and estriol excretion in 24-hr-urine. Ten out of our
15 SGAs were below the 95% ränge and 5 were
40% below the mean normal value. In most other
reports 60 to 84% of SGA deliveries showed low
estriol values with 19% false positive Undings·[l, 6,
7, 8,10,16, 18,19, 21, 23, 24, 26, 28, 29, 30, 32,
33, 65, 68, 83, 88, 89, 91]. It must be mentioned
that low estriol values need not always indicate
placental insufficiency and that normal values do
not exclude such an insufficiency [63].
This also explains the idea that growth retardation
and low estriol values may be secondary conse-
quences of abnormal fetal development [17, 34,
51, 87]. Thus low estriol values often accompanied
deformities [7, 84], genetic aberrations [63, 88]
and adrenal hypoplasia [29]. For the EPH syn-
drome in the group at risk a very good correlation
between body weight and estriol excretion was al-
ways found [26, 91]. Perinatal mortality rises up
to 45% äs growth retardation is increased [10, 26,
63, 69]. Depending on the duration of pregnancy
some define a danger zone of 5—12 mg estriol/
24 hrs [l, 26, 32, 38, 48, 63, 88] or a value less
than 25% of the mean [47]. All agree that repeated
tests must be made, since single values are of little
value. BOOG et al. [12] in contrast to us, conclude
that cephalometry is a better diagnostic tool than
estriol determinations for the diagnosis of intrau-
terine growth retardation.
Plasma estriol and estradiol levels are also decreased
during fetal growth retardation [66, 20, 56].
There was a good correlation between maternal
plasma HPL and infant weight and 8 of our 15 SGA
infants showed HPL values below the 95% normal
limit. This correlation and diagnostic reliability
with respect to SGA has been confirmed [40, 64,
79, 80, 83, 85]. Others found a relation to placen-
'tal weight [5, 73, 74] not confirmed by SCIARRA
et al. [75].
The great ränge of normal HPL levels in the last
trimester has often been considered to limit the
value and clinical use of this test [77, 79]. In order
to improve the diagnostic value and to underline
placental function a limit of 7 Mg/ml was set for
underweight infants [64] and below 4 ^g/ml for
danger to the fetus [78, 85]. Perinatal mortality
was 24% for hypertensive pregnancies and rose to
56%inseverecases.
Only one out of 15 SGA infants could be detected
from pregnandiol values. This may be due to the
wide ränge of values and may explain contradictory
reports. The correlation was confirmed [l, 46,47,
76, 91 ], suspected [71, 72] or rejected [21, 51, 52,
65]. In underweight children low [14, 16, 31, 72]
or unchanged values [65] have been reported.
In contrast to previous work [2, 19] only values
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below 95% of the normal were taken into consid-
eration for HSAP concentrations. Five out of 15
SGAs could be detected although there was no
correlation with body weight. Others also found
no correlation [18, 19, 28]. Reliabüity is reported
to vary from 13.8 to 77% [2, 3, 18, 19, 89]. A
correlation with placental weight has also been
reported [18]. Although supported by some [44,
67] HSAP concentration is of little value äs a
screening test [28, 89] even though it may reflect
a chronic placental insufficiency.
Summary
An attempt was made to make an early diagnosis of in-
trauterine growth retardation due to chronic placental
insufficiency using ultrasound cephalometry and bio-
chemical tests of placental function.
We examined 83 hospitalised patients in whom there was
a risk or suspicion of chronic placental insufficiency. For
each patient an average of 4 determinations were made
of head diameter, 10 of estriol and 3 of pregnandiol
urinary excretion, 6 serum HPL and 7 of heat stable
alkaline phosphatase (HSAP). Fetal growth retardation
was assumed if the last 2 determined head diameters were
below the normal curve with the same tendency and with
term being well predicted. Biochemical parameters were
considered to indicate pathological changes if they were
95% below normal values, with 2 below this ränge or 3
continuously falling below the normal level. Infants were
assessed after birth both neurologically and somatically
Keywords: Cephalometry, chronic placental insufficiency, estriol, pregnandiol, heat stable alkaline phosphatase, HPL,
intrauterine growth retardation.
Thus, according to our results 24-hour-urinary
estriol and HPL levels in the serum are the most
valuable parameters for' diagnosing intrauterine
growth retardation due to chronic placental in-
sufficiency. Hence serial determinations of estriol
and HPL are recommended if the case history
contains a death at delivery, dysmaturity, preg-
nancy complications such äs hypertension, chronic
renal disease, cardiac Symptoms, diabetes mellitus,
haemorrhages in the second half of pregnancy etc.
and in patients whose uterus appears small for date.
according to DUBOWITZ. Small for date infants were
those whose birth weight was below the lOth percentile
(LUBCHENKO). This was found to be the case in 15 out
of 83 newborns five of whom were younger than 37
weeks.
These 15 could be diagnosed before birth with various
degrees of certainty. For estriol and HPL this was 67% or
53% and these t wo parameters were found to be the most
valuable. Cephalometry was found to be less valuable with
20%, pregnandiol levels with 9% and placental HSAP with
33%.
Hence it is recommended to perform serial determinations
of estriol and HPL in the third trimester of pregnancy in
all patients with histories indicative of fetal growth retar-
dation and in those in whom the uterus appears small for
date.
Zusammenfassung
Ultraschallbefunde und biochemische Parameter bei in-
trauteriner Mangelentwicklung
Mittels Ultraschall-Kephalometrie und Überprüfung der
biochemischen Funktionen der fetoplazentaren Einheit
wurde der Versuch unternommen, eine intrauterine fetale
Wächstumsretardierung als Folge einer chronischen Plazen-
tarinsuffizienz möglichst frühzeitig zu erkennen.
Die Untersuchung umfaßte 83 ausgewählte, hospitalisierte
.Patientinnen mit aktuellem oder anamnestischem Risiko
und klinischem Verdacht auf eine chronische Plazentar-
insuffizienz. Pro Fall lagen im dritten Schwangerschaft-
trimenon durchschnittlich 4 Messungen des biparietalen
Kopfdurchmessers, 10 Bestimmungen der Östriol- und 3
der Pregnandiolausscheidung im Urin, 6 HPL-Werte
(Human Placental Lactogen) im Serum und 7 Messungen
der hitzestabilen alkalischen Phosphatase (HSAP) vor.
Lagen die zwei zuletzt gemessenen biparietalen Durch-
messer bei gleichbleibender Tendenz und gesichertem
Termin unterhalb der doppelten mittleren Abweichung
der Normwertkurve oder fehlte eine regelrechte Pro-
gredienz wurde eine fetale Wachstumsretardierung ange-
nommen. Bei den biochemischen Parametern wurden fol-
gende Werte als pathologisch angesehen: Abfall unter den
Schlüsselwörter: Chronische Placentarinsuffizienz, Hitzestabile alkalische Phosphatase, HPL, Intrauterine Mangelent-
wicklung, Kephalometrie, Östriol, Pregnandiol.
95%-Normbereich, wobei 2 Werte des Abfalles außerhalb
dieses Bereiches liegen mußten oder kontinuierlicher Ver-
lauf von 3 oder mehr Werten unterhalb dem Normbereich.
Die klinische Beurteilung der Kinder erfolgte postpartal
anhand der neurologischen und soihatischen Reifezeichen
nach DUBOWITZ. Als Mangelgeburt wurden Neugeborene
mit einem Geburtsgewicht unter der 10. Perzentile
(LUBCHENKO) klassiert. Diese Bedingung erfüllten 15
von 83 Neugeborenen, wovon 5 ein Gestationsalter von
weniger als 37 Wochen auf wiesen.
Die 15 intrauterinen Mangelentwicklungen konnten ante-
partal mittels den durchgeführten Serienmessungen mit
unterschiedlicher Treffsicherheit erfaßt werden. Sie be-
trug für Östriol und HPL 67% bzw. 53%, womit diesen
beiden Parametern am meisten Bedeutung zukommt. Als
weniger zuverlässig erwiesen sich mit 20% Treffsicherheit
die Kephalometrie, mit 9% die Pregnandiolbestimmung
und mit 33% das plazentare Enzym HSAP.
Serienmessungen von Östriol und HPL sind demnach im
dritten Schwangerschaftstrimenon bei allen Schwangeren
mit belasteter Anamnese und bei Patientinnen, bei denen
der Uterus "small for date" erscheint, empfehlenswert.
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Resume
Resultats ultrasoniques et biochimiques en cas de malnutri-
tion intra-uterine
A Paide de la cephalometrie ultrasonique et de l'analyse
des fonctions biochimiques de l'unite foeto-placentaire,
nous avons tente de detecter au plus tot un retard de
croissance foetale intra-uterine consecutive a une
insuffisance placentaire chronique.
L'examen a porte sur 83 parturientes hospitalisees et
selectionnees, presentant un risque actuel ou anamnesique
ainsi que clinique d'insuffisance placentaire chronique.
Pour chacun des cas, on a effectue jusqu'au troisieme
trimestre degrossesse en moyenne 4 mesurages du diametre
cranial biparietal, 10 calculs d'elimination d'oestriol et 3
de pregnandiol dans l'unne, 6 valeurs de HPL (Human
Placental Lactogen) dans le serum et 7 calculs de phos-
phatase alcaline thermostabile (HSAP). Dans les cas ou
les deux dernieres mesures du diametre biparietal sont
restes, pour une tendance stationnaire et un terme sür,
au-dessous de Fecart-type double des courbes normales et
terme sür, au-dessous de Tecart-type double des courbes
normales et oü manquait toute progression reguliere, on
a assume que la cause en etait düe a un retardement de
la crvissance foetale. Pout les parametres biochimiques,
on a considere les valeurs suivantes comme etant patho-
logiques: Baisse de la courbe de croissance au-dessous de
Mots-cles: Cephalometrie, HPL, Insuffisance placentaire chronique, malnutrition intrauterine, oestriol, pregnandiol,
phosphatase alcaline thermostabile.
la zone normale de 95% a condition que deux des valeurs
de baisse se situent en dehors de cette zone ou que la
courbe continue de 3 ou plus de ccs valeurs se maintienne
au-dessous de la zone normale. L'examen clinique des
enfants a ete effectue post partum a l'appui des signes d.
maturite neurologiques et somatiques d'apres DUBOWITZ.
On a place dans la classification de näissance carentielle
les nouveaux-nes ayant un poids a la näissance inferieur au
10. percentile (LUBCHENKO), ce qui fut le cas pour 15
des 83 nouveaux-nes dont 5 attcignirent un äge degestation
inferieur a 37 semaines.
Les 15 cas de carence intra-uterine avaient pu etre observes
ante partum avec une precision diversifiee par les s6ries de
mesures effectuees: Cettc precision a cte respectivement
de 67 et 53% pour Foestriol et le HPL qui representcnt
donc les facteurs les plus importants. Par contre, la cephalo-
metrie, la definition de pregnandiol et Fenzyme placentaire
HSAP ont apporte un degre moindre d'exactitudequi n'a
pas depasse, respectivement, 20, 9 et 33%.
En conclusion, il est recommande d'effectuer des series de
mesures d'oestriol et de HPL au 3eme trimestre degrossesse
chez toutes les femmes enceintes ayant une anamnese
«chargee» ou chez lesquelles l'uterus semble petit pour la
date de gestation.
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